Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
2.
Surg Endosc ; 33(5): 1600-1612, 2019 05.
Article in English | MEDLINE | ID: mdl-30225604

ABSTRACT

BACKGROUND: Robotic-assisted bariatric surgery is part of the armamentarium in many bariatric centers. However, limited data correlate the robotic benefits to with clinical outcomes. This study compares 30-day outcomes between robotic-assisted and laparoscopic procedures for Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). METHODS: Using the 2015-2016 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database, patients between18- and 65-year-old were included. To adjust for potential confounders, 1:1 propensity-score matching (PSM) was performed using 22 preoperative characteristics. Second PSM analysis was performed adding operative time and conversion rate. RESULTS: 269,923 patients underwent SG (n = 190,494) or RYGB (n = 79,429). The operative time was significantly longer in the Robotic-assisted compared to laparoscopic approach either for SG (102.58 ± 46 vs. 73.38 ± 36; P < 0.001) or for RYGB (158.29 ± 65 vs. 120.17 ± 56; P < 0.001). In the SG cohort (12,877 matched cases), the robotic approach showed significant reduction of postoperative bleeding (0.16% vs. 0.43%; P < 0.001) and strictures (0.19% vs. 0.33%; P = 0.04) with similar results in the other 30-day outcomes in both analyses. Similarly, for the RYGB cohort (5780 matched cases), the robotic approach showed significantly fewer requirements for blood transfusions (0.64% vs. 1.16%; P = 0.004) with no statistically different results for the other's outcomes. Conversely, when adding operative time and conversion rate to the PSM analysis, the robotic platform showed significantly shorter length of stay (2.12 ± 1.9 vs. 2.30 ± 3.1 days; P < 0.001), reduction of anastomotic leak (0.52% vs. 0.92%; P = 0.01), renal complications (0.16% vs. 0.38%; P = 0.004), and venous thromboembolism (0.24% vs. 0.52%; P = 0.02). CONCLUSIONS: Our findings show that postoperative bleeding and blood transfusion are significantly reduced with the robotic platform, and after correcting for all factors including operative time, the robotic-assisted approach is associated with better postoperative outcomes especially for RYGB.


Subject(s)
Gastrectomy/methods , Gastric Bypass/methods , Laparoscopy/methods , Obesity, Morbid/surgery , Robotic Surgical Procedures/methods , Adolescent , Adult , Aged , Bariatric Surgery/methods , Databases, Factual , Female , Follow-Up Studies , Humans , Male , Middle Aged , Propensity Score , Quality Improvement , Retrospective Studies , Treatment Outcome , Young Adult
3.
Obes Surg ; 28(5): 1225-1231, 2018 05.
Article in English | MEDLINE | ID: mdl-29455407

ABSTRACT

PURPOSE: This study's objective was to describe our experience and evaluate the safety of early discharge (ED) following laparoscopic Roux-en-Y gastric bypass (LRYGB) in a specific patient population. MATERIALS AND METHODS: Patients undergoing LRYGB at Montefiore Medical Center were retrospectively reviewed. Patients readmitted in the first 30 days following surgery were compared to those patients who were not readmitted. Data analysis was used to compare groups and to determine factors associated with readmission. In addition to patient demographics, length of stay (LOS) was analyzed as an independent risk factor for readmission. RESULTS: A total of 630 LRYGB were performed during this period. There were 5.1% (n = 32) of patients that required readmission within 30 days of discharge. Readmitted patients had a higher BMI (50.0 vs. 45.8; p = 0.006) and there was a trend for them to be younger (38.4 years vs. 42.0; p = 0.07). There was an increased rate of ED in 2015 (36.7%, n = 121) compared to 2014 (29.9%, n = 90). The readmission rate for ED for the study period was 4.7% (n = 10). There were no observed mortalities in our early discharge group of patients. CONCLUSIONS: Discharge on post-operative day 1 following a LRYGB is safe and is not associated with an increased likelihood of being readmitted within 30 days of discharge. Our single-center experience helps to better characterize current patient profiles and length of stay trends within the field and can be used to establish a randomized controlled trial for discharging patients early after LRYGB.


Subject(s)
Gastric Bypass , Length of Stay/statistics & numerical data , Patient Discharge/statistics & numerical data , Adult , Gastric Bypass/adverse effects , Gastric Bypass/methods , Gastric Bypass/statistics & numerical data , Humans , Laparoscopy/adverse effects , Laparoscopy/methods , Laparoscopy/statistics & numerical data , Patient Readmission/statistics & numerical data , Retrospective Studies , Risk Factors
4.
Plast Reconstr Surg ; 136(1): 40-49, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26111312

ABSTRACT

BACKGROUND: Lateral canthal procedures are often indicated to correct or prevent lower eyelid malposition. When determining an appropriate lateral canthal procedure, planning is essential and includes proper analysis and identification of any contributory anatomical factors. METHODS: A 12-month retrospective review was performed on patients undergoing lateral canthal procedures. Important components of the preoperative examination were studied to relate patient anatomy and results. Outcomes were followed for a minimum of 5 years. RESULTS: Of 288 consecutive lower eyelid canthal procedures, a total of 146 met the inclusion criteria. Common designated abnormal preoperative findings included a negative vector (62 percent), lid margin eversion (12 percent), scleral show (21 percent), neutral or negative canthal tilt (49 percent and 18 percent, respectively), and lateral canthus -to -orbital rim distance of more than 1 cm (11 percent). The distribution of lateral canthal procedures performed in our study population included inferior retinacular lateral canthopexy (n = 36), inferior retinacular lateral canthoplasty (n = 88), tarsal strip lateral canthoplasty (n = 15), and dermal-orbicular pennant lateral canthoplasty (n = 7). Successful outcomes were noted to be 86 percent and 91 percent according to surgeons and patients, respectively. CONCLUSIONS: Specific findings on the preoperative physical examination identify when simple or more complex lateral canthal procedures should be performed. The authors report seven key physical findings that should be documented to effectively determine a lateral canthal procedure that is appropriate for prevention and management of lower eyelid malposition. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.


Subject(s)
Blepharoplasty/methods , Eyelids/anatomy & histology , Physical Examination , Preoperative Care , Eyelids/surgery , Humans , Outcome Assessment, Health Care , Retrospective Studies
5.
Muscle Nerve ; 43(5): 741-50, 2011 May.
Article in English | MEDLINE | ID: mdl-21337346

ABSTRACT

INTRODUCTION: Over the past 10 years, the use of zebrafish for scientific research in the area of muscle development has increased dramatically. Although several protocols exist for the isolation of adult myoblast progenitors from larger fish, no standardized protocol exists for the isolation of myogenic progenitors from adult zebrafish muscle. METHODS: Using a variant of a mammalian myoblast isolation protocol, zebrafish muscle progenitors have been isolated from the total dorsal myotome. These zebrafish myoblast progenitors can be cultured for several passages and then differentiated into multinucleated, mature myotubes. RESULTS: Transcriptome analysis of these cells during myogenic differentiation revealed a strong downregulation of pluripotency genes, while, conversely, showing an upregulation of myogenic signaling and structural genes. CONCLUSIONS: Together these studies provide a simple, yet detailed method for the isolation and culture of myogenic progenitors from adult zebrafish, while further promoting their therapeutic potential for the study of muscle disease and drug screening.


Subject(s)
Aging/physiology , Gene Expression Profiling/methods , Muscle, Skeletal/physiology , Myoblasts/physiology , Stem Cells/physiology , Animals , Animals, Genetically Modified , Cell Differentiation/physiology , Cells, Cultured , Muscle Development/physiology , Muscle, Skeletal/cytology , Muscle, Skeletal/growth & development , Myoblasts/cytology , Stem Cells/cytology , Zebrafish
6.
Am J Sports Med ; 38(3): 520-6, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20194957

ABSTRACT

BACKGROUND: Chondrolysis associated with intra-articular administration of local anesthetics has been attributed to chondrocyte death induced by the local anesthetics. The mechanism of how the local anesthetics cause chondrocyte death is not clear. PURPOSE: This study was conducted to determine whether and how the local anesthetics cause chondrocyte death. STUDY DESIGN: Controlled laboratory study. METHODS: Bovine articular chondrocytes in suspension culture were treated for 1 hour with phosphate-buffered saline or phosphate-buffered saline/medium mixture (as controls); 1% lidocaine alone; 0.25% to 0.5% bupivacaine alone; phosphate-buffered saline with pH values of 4.5, 3.8, 3.4, and 2.4; or mixtures of the local anesthetics and cell culture medium or human synovial fluid. Chondrocyte viability was analyzed by flow cytometry using the LIVE/DEAD Viability/Cytotoxicity Kit. RESULTS: In 1% lidocaine-alone or 0.25% to 0.5% bupivacaine-alone groups, the rate of cell death was 11.8% to 13.3% of bovine articular chondrocytes, whereas the phosphate-buffered saline control had 8.4% of cell death. Increased chondrocyte death was only found when the pH value of phosphate-buffered saline dropped to < or = 3.4. In contrast, when bupivacaine was mixed with cell culture medium, needle-like crystals were formed, which was accompanied with 100% death of chondrocytes. Lidocaine did not form visible crystals when it was mixed with culture medium, but the mixtures caused death of over 96% of chondrocytes (P < .001). CONCLUSION: Less than 5% of chondrocyte death was attributable to the anesthetics when applied to the cells alone or in phosphate-buffered saline-diluted solution. Acidity (as low as pH 3.8) or epinephrine in the anesthetic solutions could not account for chondrocyte death. However, chemical incompatibility between the local anesthetics and cell culture medium or human synovial fluid may be the cause of chondrocyte death. CLINICAL RELEVANCE: Intra-articular administration of lidocaine and bupivacaine is not an indicated usage of either anesthetic, although such a usage has become a common practice. Physicians should be aware of the potential incompatibility of the drug and synovial fluid.


Subject(s)
Anesthetics, Local/adverse effects , Apoptosis , Cartilage, Articular/drug effects , Chondrocytes/drug effects , Synovial Fluid/drug effects , Animals , Bupivacaine/adverse effects , Cartilage, Articular/cytology , Cattle , Cells, Cultured , Chondrocytes/physiology , Epinephrine/adverse effects , Lidocaine/adverse effects , Synovial Fluid/cytology
7.
J Pharmacol Exp Ther ; 332(1): 35-45, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19797619

ABSTRACT

Glyceollins, a group of novel phytoalexins isolated from activated soy, have recently been demonstrated to be novel antiestrogens that bind to the estrogen receptor (ER) and inhibit estrogen-induced tumor progression. Our previous publications have focused specifically on inhibition of tumor formation and growth by the glyceollin mixture, which contains three glyceollin isomers (I, II, and III). Here, we show the glyceollin mixture is also effective as a potential antiestrogenic, therapeutic agent that prevents estrogen-stimulated tumorigenesis and displays a differential pattern of gene expression from tamoxifen. By isolating the individual glyceollin isomers (I, II, and III), we have identified the active antiestrogenic component by using competition binding assays with human ERalpha and in an estrogen-responsive element-based luciferase reporter assay. We identified glyceollin I as the active component of the combined glyceollin mixture. Ligand-receptor modeling (docking) of glyceollin I, II, and III within the ERalpha ligand binding cavity demonstrates a unique type II antiestrogenic confirmation adopted by glyceollin I but not isomers II and III. We further compared the effects of glyceollin I to the antiestrogens, 4-hydroxytamoxifen and ICI 182,780 (fulvestrant), in MCF-7 breast cancer cells and BG-1 ovarian cancer cells on 17beta-estradiol-stimulated expression of progesterone receptor and stromal derived factor-1alpha. Our results establish a novel inhibition of ER-mediated gene expression and cell proliferation/survival. Glyceollin I may represent an important component of a phytoalexin-enriched food (activated) diet in terms of chemoprevention as well as a novel therapeutic agent for hormone-dependent tumors.


Subject(s)
Anticarcinogenic Agents/pharmacology , Estrogen Receptor Modulators/pharmacology , Glycine max/chemistry , Pterocarpans/pharmacology , Terpenes/pharmacology , Animals , Anticarcinogenic Agents/chemistry , Anticarcinogenic Agents/isolation & purification , Anticarcinogenic Agents/therapeutic use , Binding Sites , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Estrogen Receptor Modulators/chemistry , Estrogen Receptor Modulators/isolation & purification , Estrogen Receptor Modulators/therapeutic use , Estrogen Receptor alpha/antagonists & inhibitors , Estrogen Receptor alpha/biosynthesis , Estrogen Receptor alpha/genetics , Female , Humans , Mice , Mice, Nude , Molecular Structure , Neoplasm Transplantation , Pterocarpans/chemistry , Pterocarpans/isolation & purification , Pterocarpans/therapeutic use , Sesquiterpenes , Stereoisomerism , Tamoxifen/pharmacology , Terpenes/chemistry , Terpenes/isolation & purification , Terpenes/therapeutic use , Transcription, Genetic/drug effects , Xenograft Model Antitumor Assays , Phytoalexins
8.
Endocrinology ; 150(5): 2446-53, 2009 May.
Article in English | MEDLINE | ID: mdl-19116342

ABSTRACT

The primary induced isoflavones in soybean, the glyceollins, have been shown to be potent estrogen antagonists in vitro and in vivo. The discovery of the glyceollins' ability to inhibit cancer cell proliferation has led to the analysis of estrogenic activities of other induced isoflavones. In this study, we investigated a novel isoflavone, glycinol, a precursor to glyceollin that is produced in elicited soy. Sensitive and specific in vitro bioassays were used to determine that glycinol exhibits potent estrogenic activity. Estrogen-based reporter assays were performed, and glycinol displayed a marked estrogenic effect on estrogen receptor (ER) signaling between 1 and 10 microM, which correlated with comparable colony formation of MCF-7 cells at 10 microM. Glycinol also induced the expression of estrogen-responsive genes (progesterone receptor and stromal-cell-derived factor-1). Competitive binding assays revealed a high affinity of glycinol for both ER alpha (IC(50) = 13.8 nM) and ER beta (IC(50) = 9.1 nM). In addition, ligand receptor modeling (docking) studies were performed and glycinol was shown to bind similarly to both ER alpha and ER beta. Taken together, these results suggest for the first time that glycinol is estrogenic and may represent an important component of the health effects of soy-based foods.


Subject(s)
Fermentation/physiology , Flavonols/isolation & purification , Glycine max/chemistry , Glycine max/metabolism , Phytoestrogens/isolation & purification , Binding, Competitive , Cell Proliferation/drug effects , Cells, Cultured , Drug Evaluation, Preclinical , Estrogens/isolation & purification , Estrogens/metabolism , Estrogens/pharmacology , Flavonols/chemistry , Flavonols/metabolism , Flavonols/pharmacology , Gene Expression Regulation/drug effects , Humans , Models, Biological , Models, Molecular , Phytoestrogens/chemistry , Phytoestrogens/metabolism , Phytoestrogens/pharmacology , Pterocarpans/chemistry , Receptors, Estrogen/metabolism , Receptors, Estrogen/physiology , Transcription, Genetic/drug effects
9.
Dev Biol ; 309(2): 180-92, 2007 Sep 15.
Article in English | MEDLINE | ID: mdl-17678642

ABSTRACT

Titin (also called connectin) acts as a scaffold for signaling proteins in muscle and is responsible for establishing and maintaining the structure and elasticity of sarcomeres in striated muscle. Several human muscular dystrophies and cardiomyopathies have previously been linked to mutations in the titin gene. This study reports linkage of the runzel homozygous lethal muscular dystrophy in the zebrafish Danio rerio to a genomic interval containing the titin gene. Analysis of the genomic sequence suggests that zebrafish contain two adjacent titin loci. One titin locus lies within the genetic linkage interval and its expression is significantly reduced in runzel mutants by both immunofluorescence and protein electrophoresis. Morpholino downregulation of this same titin locus in wild-type embryos results in decreased muscle organization and mobility, phenocopying runzel mutants. Additional protein analysis demonstrates that, in wild-type zebrafish, titin isoform sizes are rapidly altered during the development of striated muscle, likely requiring a previously unrecognized need for vertebrate sarcomere remodeling to incorporate developmentally regulated titin isoforms. Decreases of affected titin isoforms in runzel mutants during this time correlate with a progressive loss of sarcomeric organization and suggest that the unaffected titin proteins are capable of sarcomerogenesis but not sarcomere maintenance. In addition, microarray analysis of the ruz transcriptome suggests a novel mechanism of dystrophy pathogenesis, involving mild increases in calpain-3 expression and upregulation of heat shock proteins. These studies should lead to a better understanding of titin's role in normal and diseased muscle.


Subject(s)
Fish Diseases/genetics , Muscle Proteins/metabolism , Muscular Dystrophy, Animal/genetics , Protein Kinases/metabolism , Zebrafish Proteins/metabolism , Zebrafish , Animals , Connectin , Fish Diseases/metabolism , Gene Expression Regulation, Developmental , Genetic Linkage , Muscle Proteins/genetics , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Muscle, Skeletal/ultrastructure , Muscular Dystrophy, Animal/metabolism , Mutation , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Kinases/genetics , Sarcomeres/metabolism , Sarcomeres/ultrastructure , Zebrafish Proteins/genetics
10.
Biochim Biophys Acta ; 1772(2): 205-15, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16934958

ABSTRACT

Zebrafish reproduce in large quantities, grow rapidly, and are transparent early in development. For these reasons, zebrafish have been used extensively to model vertebrate development and disease. Like mammals, zebrafish express dystrophin and many of its associated proteins early in development and these proteins have been shown to be vital for zebrafish muscle stability. In dystrophin-null zebrafish, muscle degeneration becomes apparent as early as 3 days post-fertilization (dpf) making the zebrafish an excellent organism for large-scale screens to identify other genes involved in the disease process or drugs capable of correcting the disease phenotype. Being transparent, developing zebrafish are also an ideal experimental model for monitoring the fate of labeled transplanted cells. Although zebrafish dystrophy models are not meant to replace existing mammalian models of disease, experiments requiring large numbers of animals may be best performed in zebrafish. Results garnered from using this model could lead to a better understanding of the pathogenesis of the muscular dystrophies and the development of future therapies.


Subject(s)
Disease Models, Animal , Muscular Dystrophies/genetics , Muscular Dystrophies/pathology , Zebrafish/genetics , Animals , Humans , Muscular Dystrophies/etiology , Muscular Dystrophies/therapy , Zebrafish/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...